Close Menu

influenza

Doing so, however, will require the company to secure additional funding, and it is currently evaluating its options, a company official said.

CPGR will be developing multiplex protein array-based antibody profiling assays and related bioinformatic analysis methods for the project with the ultimate aim of creating a biomarker signature that can be used for companion diagnostic purposes.

Through their phylogenetic analysis of influenza A strains circulating in pigs at a Hong Kong slaughterhouse, researchers have detected viral reassortment involving the H1N1 "swine flu" virus.

The partners aim to identify biomarkers that may predict how patients react to seasonal influenza vaccinations.

"The discovery of svRNAs that play a critical role in flu virus replication opens the door for the development of novel RNA therapeutics for the treatment of flu infection, an area of major unmet need," according to an Alnylam official.

Simplexa, manufactured by Quest's Focus Diagnostics business, is the first test to be cleared by the FDA to aid in detecting and differentiating influenza A and 2008 H1N1 influenza viral RNA.

As a result of the 510(k) clearance, Quest's Simplexa Influenza A H1N1 test will be the only one that can be marketed after June 23 when the public emergency stemming from the virus is lifted.

The vote of confidence is a stepping stone for the company to seek 510(k) approval for an H1N1 test on its platform; to tackle the point-of-care diagnostic market; and to further develop tests for other infectious diseases.

IQuum said that it has developed a nucleic acid-based test that can provide results in just 26 minutes.

Idaho Tech's Joint Biological Agent Identification and Diagnostic System system and newly developed tests will be used to test military personnel and their families for influenza A and B, and subtypes of A.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.